双侧卵巢癌患者体外获取成熟中期II卵母细胞首例妊娠并活产:一例病例报告
一例34岁未育女性双侧卵巢肿瘤,恶性风险96.1%,在根治手术前要求保留生育力。卵巢切除标本体外获取12枚中期II卵母细胞并玻璃化冷冻,缓解期行卵胞浆内单精子注射(供精)获9枚卵裂期胚胎,移植2枚给代孕者,获正常健康单胎妊娠并活产健康婴儿。
要点
- 双侧卵巢癌患者可在卵巢切除标本中体外获取成熟卵母细胞进行生育力保存。
- 体外获取的12枚中期II卵母细胞经供精ICSI获9枚卵裂期胚胎。
- 移植2枚胚胎给代孕者获正常健康单胎妊娠并活产健康婴儿。
核心结论
- 卵巢切除后体外获取卵母细胞可能是卵巢恶性肿瘤女性生育力保存的安全替代方案。
研究设计与样本
- 病例报告,地点为生育门诊,患者为34岁未育女性双侧卵巢肿瘤。
主要发现
- 根据国际卵巢肿瘤分析组附件肿瘤推荐,恶性风险为96.1%。
- 控制性卵巢刺激后,从卵巢切除标本获取12枚中期II卵母细胞并玻璃化冷冻。
- 缓解期行供精卵胞浆内单精子注射,获9枚卵裂期胚胎,移植2枚给代孕者。
- 获正常健康单胎妊娠并活产健康婴儿。
临床怎么用
- 作者认为卵巢切除后体外获取卵母细胞可能是卵巢恶性肿瘤女性生育力保存的安全替代方案。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report pregnancy and live birth resulting from intracytoplasmic sperm injection of ex vivo-retrieved mature oocytes from a woman with bilateral ovarian carcinoma. DESIGN: Case report. SETTING: Fertility clinic. PATIENT: A 34-year-old nulliparous woman with bilateral ovarian tumor, with a risk of malignancy of 96.1% according to International Ovarian Tumor Analysis Group recommendations for adnexal tumors, who desired fertility preservation before definitive surgical treatment. INTERVENTION(S): Cryopreservation of ex vivo-retrieved mature metaphase II oocytes is followed by fertilization with donor sperm and embryo transfer to a gestational carrier. MAIN OUTCOME MEASURE(S): Fertility preservation. RESULTS: After controlled ovarian stimulation, 12 metaphase II oocytes were retrieved from oophorectomized specimens and vitrified. Intracytoplasmic sperm injection with donor sperm was performed in remission, resulting in 9 cleavage-stage embryos, 2 of which were transferred to a gestational carrier, resulting in a normal, healthy singleton pregnancy, and the live birth of a healthy infant. CONCLUSION(S): Ex vivo oocyte retrieval after oophorectomy may be a safe alternative to standard oocyte retrieval for fertility preservation in women with ovarian malignancies.
引用
- de Carvalho BR, Cintra GF, Cabral ÍO, et al. First pregnancy and live birth from ex vivo-retrieved metaphase II oocytes from a woman with bilateral ovarian carcinoma: a case report. Fertil Steril. 2024. PMID: 38316207. doi:10.1016/j.fertnstert.2024.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。